Please assess the completion status of the following clinical trial:

Trial Title: The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with endometrial polyps.~Exclusion Criteria:~* Patients with other endometrial pathologies.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Control (Type: NO_INTERVENTION): Patients with endometrial polyps undergone hysteroscopic polipectomy without endometrial preparation.
- Intervention (Type: EXPERIMENTAL): Patients with endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Nomegestrol Acetate/Estradiol 2.5mg/1.5mg at any time of the menstrual cycle

Based on this trial design, predict the completion outcome and termination type (if applicable).